3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Ticlopidine: new trials by email Literature Review of Ticlopidine trials Research Report on Ticlopidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROMUS Element Plus US Post-Approval Study PROMUS Element Plus Coronary Stent System, Aspirin, P2Y12 antagonist - Coronary Artery Disease | Phase 4 | Completed | Boston Scientific Corporation | 2681 | 2012-05-01 | 2018-07-26 |
| Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol Placebo, Ticlopidine, Ticlopidine and itraconazole - Pharmacokinetics, Pharmacodynamics | Phase 4 | Completed | Turku University Hospital | 12 | 2010-09-01 | 2011-04-13 |
| Antiplatelet Therapy to Prevent Stroke in African Americans aspirin, ticlopidine - Stroke, Cerebral Infarction | Phase 4 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 2005-06-24 |
Atherosclerosis (1) · Cerebral Infarction (1) · Coronary Artery Disease (1) · Stroke (1)
Boston Scientific Corporation (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Turku University Hospital (1)
United States (2) · Finland (1)
Klaus T Olkkola, MD, PhD, Prof (1) · Peter M Maurer, MPH (1) · Philip B. Gorelick, M.D., M.P.H (1)